Page 9 - Grifols Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Grifols group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Grifols Group Today - Breaking & Trending Today

Grifols (NASDAQ:GRFS) Rating Lowered to Hold at StockNews.com

StockNews.com lowered shares of Grifols (NASDAQ:GRFS – Free Report) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning. Separately, Morgan Stanley upgraded Grifols from an equal weight rating to an overweight rating in a research report on Wednesday, April 12th. Four equities research analysts have rated […] ....

United States , Nova Scotia , Albutein Flexbag , Vistaseal Veraseal , Us Bancorp , Morgan Stanley , Raymond James Associates , Blackrock Inc , Advisor Group Holdings Inc , Financial Services Group Inc , Grifols Company Profile , Free Report , Group Holdings , Services Group , Get Free Report , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs , Stocknews Com ,

Grifols (NASDAQ:GRFS) Trading 6% Higher

Grifols, S.A. (NASDAQ:GRFS – Get Free Report)’s stock price traded up 6% during mid-day trading on Tuesday . The company traded as high as $10.56 and last traded at $10.41. 1,145,465 shares were traded during mid-day trading, an increase of 32% from the average session volume of 869,458 shares. The stock had previously closed at […] ....

United States , Vistaseal Veraseal , Albutein Flexbag , Susquehanna International Securities Ltd , Quadrant Capital Group , Ronald Blue Trust Inc , Grifols Company Profile , Morgan Stanley , Get Free Report , Financial Advisors , Blue Trust , Capital Group , Susquehanna International Securities , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs ,

Grifols (NASDAQ:GRFS) Stock Price Up 6%

Shares of Grifols, S.A. (NASDAQ:GRFS – Get Free Report) rose 6% during mid-day trading on Tuesday . The company traded as high as $10.56 and last traded at $10.41. Approximately 1,145,465 shares changed hands during trading, an increase of 32% from the average daily volume of 869,458 shares. The stock had previously closed at $9.82. […] ....

United States , Albutein Flexbag , Vistaseal Veraseal , First Trust Advisors , Norges Bank , America Corp , Morgan Stanley , Get Free Report , Trust Advisors , Investment Partners , World Investors , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs ,